Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations

Matthew Cossack, Cameron Ghaffary, Patrice Watson, Carrie Snyder, Henry T. Lynch

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Previous studies have shown that male BRCA mutation carriers stand at increased risk of developing prostate cancer and have concerns about developing cancer. Genetic counseling practitioners often discuss strategies for reducing the risk of cancer for patients at high risk due to their genetic background. Addressing modifiable health habits is one such strategy. Unfortunately, modifiable risk factors for prostate cancer have only been documented in the general population and have not yet been studied in the BRCA carrier subpopulation. Therefore, this study aimed to identify modifiable risk factors for prostate cancer in BRCA carriers. We examined prostate cancer risk factors in 74 men who were part of families with a BRCA mutation. This study examined nine dichotomous variables including: exercise, history of vasectomy, smoking history, alcohol use, finasteride use, statin use, aspirin use, coffee use, and vitamin use. The survey was sent to all cases of prostate cancer in the Hereditary Cancer Center Database at Creighton University with a known BRCA status. This study confirmed the protective benefits of daily aspirin use, which have been observed in previous studies of the general population, and suggests its benefit in BRCA carriers. Protective benefits from regular vigorous exercise and daily coffee use trended towards significance, but neither factor withstood the Bonferroni Correction for multiple comparisons.

Original languageEnglish
Pages (from-to)187-191
Number of pages5
JournalJournal of Genetic Counseling
Volume23
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Aspirin
Prostatic Neoplasms
Mutation
Coffee
Exercise
Finasteride
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Vasectomy
Neoplasms
Genetic Counseling
Vitamins
Population
Habits
Smoking
History
Alcohols
Databases
Health

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)

Cite this

Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations. / Cossack, Matthew; Ghaffary, Cameron; Watson, Patrice; Snyder, Carrie; Lynch, Henry T.

In: Journal of Genetic Counseling, Vol. 23, No. 2, 2014, p. 187-191.

Research output: Contribution to journalArticle

Cossack, Matthew ; Ghaffary, Cameron ; Watson, Patrice ; Snyder, Carrie ; Lynch, Henry T. / Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations. In: Journal of Genetic Counseling. 2014 ; Vol. 23, No. 2. pp. 187-191.
@article{e9e7ac583b11439bad0b5619580da2d3,
title = "Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations",
abstract = "Previous studies have shown that male BRCA mutation carriers stand at increased risk of developing prostate cancer and have concerns about developing cancer. Genetic counseling practitioners often discuss strategies for reducing the risk of cancer for patients at high risk due to their genetic background. Addressing modifiable health habits is one such strategy. Unfortunately, modifiable risk factors for prostate cancer have only been documented in the general population and have not yet been studied in the BRCA carrier subpopulation. Therefore, this study aimed to identify modifiable risk factors for prostate cancer in BRCA carriers. We examined prostate cancer risk factors in 74 men who were part of families with a BRCA mutation. This study examined nine dichotomous variables including: exercise, history of vasectomy, smoking history, alcohol use, finasteride use, statin use, aspirin use, coffee use, and vitamin use. The survey was sent to all cases of prostate cancer in the Hereditary Cancer Center Database at Creighton University with a known BRCA status. This study confirmed the protective benefits of daily aspirin use, which have been observed in previous studies of the general population, and suggests its benefit in BRCA carriers. Protective benefits from regular vigorous exercise and daily coffee use trended towards significance, but neither factor withstood the Bonferroni Correction for multiple comparisons.",
author = "Matthew Cossack and Cameron Ghaffary and Patrice Watson and Carrie Snyder and Lynch, {Henry T.}",
year = "2014",
doi = "10.1007/s10897-013-9629-8",
language = "English",
volume = "23",
pages = "187--191",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "2",

}

TY - JOUR

T1 - Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations

AU - Cossack, Matthew

AU - Ghaffary, Cameron

AU - Watson, Patrice

AU - Snyder, Carrie

AU - Lynch, Henry T.

PY - 2014

Y1 - 2014

N2 - Previous studies have shown that male BRCA mutation carriers stand at increased risk of developing prostate cancer and have concerns about developing cancer. Genetic counseling practitioners often discuss strategies for reducing the risk of cancer for patients at high risk due to their genetic background. Addressing modifiable health habits is one such strategy. Unfortunately, modifiable risk factors for prostate cancer have only been documented in the general population and have not yet been studied in the BRCA carrier subpopulation. Therefore, this study aimed to identify modifiable risk factors for prostate cancer in BRCA carriers. We examined prostate cancer risk factors in 74 men who were part of families with a BRCA mutation. This study examined nine dichotomous variables including: exercise, history of vasectomy, smoking history, alcohol use, finasteride use, statin use, aspirin use, coffee use, and vitamin use. The survey was sent to all cases of prostate cancer in the Hereditary Cancer Center Database at Creighton University with a known BRCA status. This study confirmed the protective benefits of daily aspirin use, which have been observed in previous studies of the general population, and suggests its benefit in BRCA carriers. Protective benefits from regular vigorous exercise and daily coffee use trended towards significance, but neither factor withstood the Bonferroni Correction for multiple comparisons.

AB - Previous studies have shown that male BRCA mutation carriers stand at increased risk of developing prostate cancer and have concerns about developing cancer. Genetic counseling practitioners often discuss strategies for reducing the risk of cancer for patients at high risk due to their genetic background. Addressing modifiable health habits is one such strategy. Unfortunately, modifiable risk factors for prostate cancer have only been documented in the general population and have not yet been studied in the BRCA carrier subpopulation. Therefore, this study aimed to identify modifiable risk factors for prostate cancer in BRCA carriers. We examined prostate cancer risk factors in 74 men who were part of families with a BRCA mutation. This study examined nine dichotomous variables including: exercise, history of vasectomy, smoking history, alcohol use, finasteride use, statin use, aspirin use, coffee use, and vitamin use. The survey was sent to all cases of prostate cancer in the Hereditary Cancer Center Database at Creighton University with a known BRCA status. This study confirmed the protective benefits of daily aspirin use, which have been observed in previous studies of the general population, and suggests its benefit in BRCA carriers. Protective benefits from regular vigorous exercise and daily coffee use trended towards significance, but neither factor withstood the Bonferroni Correction for multiple comparisons.

UR - http://www.scopus.com/inward/record.url?scp=84896985845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896985845&partnerID=8YFLogxK

U2 - 10.1007/s10897-013-9629-8

DO - 10.1007/s10897-013-9629-8

M3 - Article

C2 - 23881471

AN - SCOPUS:84896985845

VL - 23

SP - 187

EP - 191

JO - Journal of Genetic Counseling

JF - Journal of Genetic Counseling

SN - 1059-7700

IS - 2

ER -